| __timestamp | Galapagos NV | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 94103000 |
| Thursday, January 1, 2015 | 129714000 | 146194000 |
| Friday, January 1, 2016 | 139574000 | 130000 |
| Sunday, January 1, 2017 | 218502000 | 7353000 |
| Monday, January 1, 2018 | 322876000 | 34193000 |
| Tuesday, January 1, 2019 | 427320000 | 56586000 |
| Wednesday, January 1, 2020 | 523667000 | 63382000 |
| Friday, January 1, 2021 | 1629000 | 97049000 |
| Saturday, January 1, 2022 | 12079000 | 139989000 |
| Sunday, January 1, 2023 | 35989000 | 150343000 |
Unleashing the power of data
In the ever-evolving biotech landscape, understanding cost structures is pivotal. This analysis delves into the cost of revenue trends for Galapagos NV and Sarepta Therapeutics, Inc. over the past decade. Galapagos NV, a Belgian biotech firm, saw its cost of revenue peak in 2020, reaching nearly 523 million, a staggering 370% increase from 2014. However, a sharp decline followed, with costs plummeting to just 3% of the 2020 peak by 2021. Meanwhile, Sarepta Therapeutics, Inc., based in the U.S., exhibited a more consistent upward trajectory, with costs rising by approximately 60% from 2014 to 2023. This divergence highlights the contrasting financial strategies and market conditions faced by these companies. As the biotech sector continues to innovate, monitoring such financial metrics offers invaluable insights into corporate health and strategic direction.
Cost of Revenue Trends: Johnson & Johnson vs Sarepta Therapeutics, Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Sarepta Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Sarepta Therapeutics, Inc.
Cost of Revenue: Key Insights for GSK plc and Galapagos NV
United Therapeutics Corporation vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Evotec SE's Expenses
Halozyme Therapeutics, Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored